Axonics, Inc. (NASDAQ:AXNX) Q4 2022 Earnings Conference Call March 1, 2023 4:30 PM ET

Company Participants

Neil Bhalodkar - VP of IR

Raymond Cohen - CEO

Dan Dearen - President and CFO

Conference Call Participants

Travis Steed - Bank of America

Larry Biegelsen - Wells Fargo

Chris Pasquale - Nephron Research

Cecilia Furlong - Morgan Stanley

David Rescott - Truist

Adam Maeder - Piper Sandler

Michael Polark - Wolfe Research

Shagun Singh - RBC Capital Markets

Michael Sarcone - Jefferies

Mike Matson - Needham and Company

Operator

Good day and thank you for standing by. Welcome to Axonics' Fourth Quarter 2022 Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session [Operator Instructions] Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your host today, Neil Bhalodkar. Please go ahead.

Neil Bhalodkar

Thank you, Shannon. Good afternoon and thank you for joining Axonics' fourth quarter 2022 results conference call. Presenting on today's call are Raymond Cohen, Chief Executive Officer; and Dan Dearen, President and Chief Financial Officer.

Before we begin, I'd like to remind listeners that statements made on this conference call that relate to future plans, events, prospects, or performance are forward-looking statements as defined under the Private Securities Litigation Reform Act of 1995. While these forward-looking statements are based on management's current expectations and beliefs, these statements are subject to a number of risks, uncertainties, assumptions, and other factors that could cause results to differ materially from the expectations expressed on this conference call.

These risks and uncertainties are disclosed in more detail in Axonics' filings with the Securities and Exchange Commission, all of which are available online at www.sec.gov. Listeners are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date, March 1, 2023. Except as required by law, Axonics undertakes no obligation to update or revise any forward-looking statements to reflect new information, circumstances, or unanticipated events that may arise.

I would now like to turn the call over to Ray.

Raymond Cohen

Thanks, Neil.

I'd like to welcome everyone joining this afternoon's call. So our fourth quarter of 2022 and the financial results were nothing short of outstanding. Axonics generated record revenue of $86 million, an increase of 62% compared to the prior year period. This marked the third quarter in a row in which our revenue has grown at least 50% year-over-year.